YGR168C Antibody

What is YGR168C and why is it significant for peroxisome research?

YGR168C (PEX35) is a previously uncharacterized gene that functions as a bona fide regulator of peroxisome number and size in yeast. Deletion of this gene causes a dramatic decrease in peroxisome abundance, comparable to defects observed in known peroxisomal biogenesis and inheritance proteins Pex12 and Vps1 . The significance of YGR168C lies in its essential role in peroxisome regulation, as evidenced by phenotypic changes observed across multiple experimental conditions and detection methods. Studies using different peroxisomal markers consistently demonstrate that loss of YGR168C leads to significant reduction in peroxisome number per cell when compared to control strains . Understanding this protein advances our knowledge of fundamental peroxisome biology and regulatory mechanisms.

How is YGR168C/PEX35 protein structurally characterized?

YGR168C/PEX35 is predicted to be a membrane protein with five transmembrane domains and a large C-terminal domain facing the cytosol . Localization studies using both C- and N-terminal fluorescent tags under control of medium-strength promoters have confirmed that YGR168C localizes to punctate structures that completely colocalize with peroxisomal markers like Pex3-mCherry or Pex3-GFP . The protein's expression under its native promoter in glucose medium is very low, often below the detection threshold of standard fluorescence microscopy. These structural characteristics are consistent with its functional role in peroxisome membrane dynamics and organization.

What experimental controls should be considered when using antibodies to study YGR168C/PEX35?

When designing experiments using antibodies against YGR168C/PEX35, proper isotype controls are essential. These control antibodies should match the exact host species, isotype, and subclass of the primary targeting antibody while having no specificity to proteins present in the target organism . This matching is crucial because primary antibodies can interact non-antigen specifically with Fc receptors on cells, potentially resulting in observable biological effects not related to antigen-specific binding .

For yeast experiments, researchers should be particularly cautious when using antibodies generated in other species (such as rat or hamster antibodies). Multiple injections of xenogeneic antibodies into model organisms can lead to immune responses against the injected antibody, potentially confounding experimental results . Including appropriate matched isotype controls allows researchers to differentiate between results observed from primary antibody binding in an antigen-specific manner versus non-antigen specific effects.

How does the multi-lobular peroxisome phenotype caused by YGR168C/PEX35 overexpression inform our understanding of peroxisome dynamics?

The overexpression of YGR168C/PEX35 leads to a striking multi-lobular peroxisome morphology as revealed by stimulated emission depletion (STED) microscopy . This phenotype provides significant insights into peroxisome membrane dynamics and potential mechanisms of peroxisome proliferation. The multi-lobular morphology could result from either hyper-fission of organelles into tiny peroxisomes that subsequently clump together (appearing as single large peroxisomes under conventional fluorescence microscopy) or the initiation of a proliferation process that aborts at an early stage .

Both scenarios support a role for YGR168C in controlling peroxisome fission. Consequently, the loss of YGR168C may cause the opposite effect—reduction in fission—explaining the observed reduction in peroxisome number . This understanding contributes to broader knowledge of peroxisome biogenesis pathways and membrane remodeling mechanisms, areas with significant implications for human peroxisomal disorders research.

What are the methodological considerations for distinguishing epitope-specific binding from non-specific interactions when using YGR168C/PEX35 antibodies?

When studying YGR168C/PEX35 using antibodies, researchers must carefully distinguish between epitope-specific binding and non-specific interactions. Drawing from antibody research principles, this requires proper selection of isotype control antibodies that match the primary antibody's characteristics but lack target specificity . To verify epitope-specific binding, researchers should employ multiple complementary approaches:

• Validate antibody specificity using YGR168C deletion strains (Δygr168c) as negative controls

• Perform competitive binding assays with purified YGR168C protein

• Verify results using alternative detection methods such as mass spectrometry

• Conduct cross-reactivity testing against related PEX proteins

Similar to how neutralizing antibody research requires careful epitope mapping , researchers working with YGR168C antibodies should consider employing structural biology approaches to confirm binding specificity. Crystal structures of antibody-antigen complexes can provide definitive evidence of binding site specificity, as demonstrated in SARS-CoV-2 antibody research where tripartite complexes were used to confirm non-overlapping epitopes .

How might convergent antibody responses influence the development of YGR168C/PEX35 antibodies for research applications?

The phenomenon of convergent antibody responses, as observed with VH3-53/VH3-66 derived antibodies against SARS-CoV-2 , raises important considerations for developing effective YGR168C/PEX35 antibodies. This concept of stereotypic antibody responses—where antibodies from different individuals share highly similar gene segments and conserved sequences—provides insights for optimizing antibody development strategies.

When generating antibodies against YGR168C/PEX35, researchers should consider screening for naturally occurring convergent antibody responses that might target immunodominant epitopes. Identifying such convergent antibodies could:

• Reveal functionally important domains within YGR168C/PEX35

• Provide antibodies with superior specificity and affinity

• Allow for the development of complementary antibody pairs targeting non-overlapping epitopes

Just as BD-368-2 and VH3-53/VH3-66 antibodies target non-overlapping epitopes on SARS-CoV-2 RBD , developing complementary YGR168C/PEX35 antibodies targeting different protein domains would enable more comprehensive protein characterization and functional studies.

What are the optimal strategies for fluorescent tagging of YGR168C/PEX35 while maintaining protein function?

• Promoter strength: Native expression of YGR168C is very low in glucose medium, often below detection thresholds. Medium-strength promoters like TEF1 can provide sufficient expression for visualization .

• Expression level considerations: Overexpression of YGR168C leads to altered peroxisome morphology . Therefore, researchers should carefully titrate expression levels, potentially using inducible promoter systems to maintain near-physiological protein levels.

• Tag selection: Bright fluorescent proteins like mCherry or enhanced GFP variants are recommended due to the relatively low abundance of peroxisomes and potentially low YGR168C expression.

• Verification of functionality: Tagged constructs should be validated by complementation testing in Δygr168c strains to ensure the tagged protein retains normal function.

How can researchers distinguish between direct and indirect effects of YGR168C/PEX35 antibodies in peroxisome proliferation studies?

Distinguishing between direct and indirect effects of antibodies in peroxisome proliferation studies requires rigorous experimental controls. Drawing from methodological principles used in neutralizing antibody research , researchers studying YGR168C/PEX35 should employ:

• Isotype-matched control antibodies: These controls should match the host species, isotype, and subclass of the primary antibody but lack specificity for the target protein .

• Fab fragment comparisons: Using Fab fragments that lack Fc regions eliminates potential Fc receptor-mediated effects, allowing researchers to isolate direct antigen binding effects .

• Dose-response relationships: Establishing clear dose-response curves for both full antibodies and Fab fragments can help distinguish specific from non-specific effects.

• Genetic validation: Complementary genetic approaches (knockdown, overexpression, domain mutations) should be used to confirm antibody-based findings.

• Temporal analyses: Monitoring the time course of peroxisome changes after antibody treatment can help differentiate primary effects from secondary adaptations.

What super-resolution microscopy techniques are most appropriate for studying YGR168C/PEX35-associated peroxisome morphology changes?

Super-resolution microscopy has proven crucial for accurately characterizing the morphological changes in peroxisomes associated with YGR168C/PEX35 manipulation. Standard confocal microscopy failed to reveal the true nature of the enlarged peroxisomes in YGR168C overexpression strains, which appeared as single large peroxisomes but actually exhibited multi-lobular morphology when visualized using stimulated emission depletion (STED) microscopy .

For researchers studying YGR168C/PEX35-associated peroxisome morphology, the following super-resolution approaches are recommended:

• STED microscopy: This technique has already demonstrated value for revealing the multi-lobular phenotype in YGR168C overexpression strains . STED is particularly useful for visualizing membrane morphology.

• Single-molecule localization microscopy (PALM/STORM): These approaches can provide even higher resolution (~10-20nm) and are well-suited for quantifying protein distribution within peroxisomal membranes.

• Structured illumination microscopy (SIM): While offering more modest resolution improvements (~100nm), SIM provides faster acquisition speeds for live-cell imaging of dynamic peroxisome processes.

• Expansion microscopy: Physical expansion of samples combined with standard confocal microscopy can provide an alternative approach for visualizing fine peroxisome structures.

Each technique requires specific sample preparation considerations, particularly regarding the choice of fluorescent tags and labeling strategies to achieve optimal signal-to-noise ratios.

How should researchers account for YGR168C/PEX35 expression levels when designing immunofluorescence experiments?

When designing immunofluorescence experiments to study YGR168C/PEX35, researchers must carefully account for the protein's naturally low expression levels. As observed in the literature, YGR168C expression under its native promoter in glucose medium is very low, often below the detection threshold of standard fluorescence microscopy . To address this challenge, researchers should consider:

• Signal amplification approaches:

  • Use high-affinity primary antibodies combined with signal-amplifying secondary detection systems

  • Consider tyramide signal amplification or other enzymatic amplification methods

  • Employ photoswitchable fluorophores with single-molecule localization microscopy for enhanced sensitivity

• Expression level manipulation:

  • Use defined promoter systems (such as TEF1) for controlled expression

  • Design time-course experiments that capture protein dynamics under different carbon sources

  • Quantify relative expression levels using western blotting to correlate with microscopy findings

• Controls for specificity:

  • Include Δygr168c strains as negative controls

  • Use peptide competition assays to confirm antibody specificity

  • Perform dual-labeling with different antibodies targeting separate epitopes

This methodical approach ensures that experimental design accounts for the challenging expression characteristics of YGR168C/PEX35.

What are the optimal protein extraction methods for preserving YGR168C/PEX35 structure for antibody-based detection?

As a predicted membrane protein with five transmembrane domains , YGR168C/PEX35 presents specific challenges for protein extraction and subsequent antibody-based detection. Optimal extraction methods must preserve protein structure while effectively solubilizing membrane components:

• Detergent selection: Mild non-ionic detergents (e.g., digitonin, DDM, or CHAPS) are preferable for maintaining the native conformation of membrane proteins with multiple transmembrane domains.

• Buffer composition:

  • Use buffers with physiological pH (7.2-7.4)

  • Include protease inhibitors to prevent degradation

  • Consider including stabilizing agents like glycerol (10-15%)

  • Maintain ionic strength similar to cytosolic conditions

• Physical disruption methods:

  • For yeast cells, glass bead disruption under gentle conditions

  • Avoid excessive heat generation during disruption

  • Consider using enzymatic methods (zymolyase) for partial cell wall digestion before gentle lysis

• Fractionation approach:

  • Differential centrifugation to isolate peroxisome-enriched fractions

  • Density gradient separation for further purification

  • Consider native extraction conditions versus denaturing conditions depending on the antibody requirements

These methodological considerations are essential for preserving the structural integrity of YGR168C/PEX35, particularly when targeting conformational epitopes that might be disrupted by harsh extraction conditions.

How can researchers effectively combine antibody-based detection with genetic manipulation to study YGR168C/PEX35 function?

Integrating antibody-based detection with genetic manipulation provides a powerful approach for studying YGR168C/PEX35 function. Drawing from methodological principles in the literature, researchers should consider:

• Complementary genetic approaches:

  • Generate clean deletion strains (Δygr168c) as negative controls for antibody specificity

  • Create point mutants affecting specific domains to correlate structure with function

  • Develop conditional expression systems (e.g., GAL promoter) for temporal control

• Epitope tagging strategies:

  • Insert small epitope tags (HA, FLAG, Myc) at different positions to enable antibody detection while minimizing functional disruption

  • Compare results with C- and N-terminal tagged constructs to identify optimal tagging positions

  • Validate tagged constructs functionally by complementation testing

• Integrated experimental design:

  • Perform parallel analysis using both antibody detection and visualization of fluorescently tagged proteins

  • Validate antibody specificity using genetic knockouts

  • Correlate protein localization patterns with peroxisome morphology changes

This integrated approach provides multiple lines of evidence for protein function while controlling for potential artifacts from either antibody binding or genetic manipulation alone.

How should researchers interpret seemingly contradictory phenotypes when YGR168C/PEX35 is either deleted or overexpressed?

One intriguing finding in YGR168C/PEX35 research is that both deletion and overexpression lead to reduced peroxisome abundance, as measured by fluorescent puncta counts . This seemingly contradictory result requires careful interpretation:

• Mechanistic hypothesis:

  • The similar phenotypic outcome may reflect different underlying mechanisms

  • Deletion likely impairs normal peroxisome biogenesis or division

  • Overexpression appears to cause aberrant multi-lobular structures, potentially through hyper-fission or aborted proliferation

• Methodological considerations:

  • The method of quantifying peroxisomes significantly impacts observations

  • Standard fluorescence microscopy can misrepresent the true peroxisome morphology

  • Super-resolution approaches like STED microscopy reveal that apparent "enlarged" peroxisomes in overexpression strains actually exhibit multi-lobular morphology

• Dosage sensitivity interpretation:

  • YGR168C/PEX35 likely functions optimally within a narrow concentration range

  • Both insufficient and excessive protein disrupt normal peroxisome dynamics

  • This suggests YGR168C/PEX35 may function in a complex with other proteins, where stoichiometry is critical

These findings illustrate the importance of combining multiple methodological approaches, including super-resolution microscopy and quantitative analysis, to accurately interpret complex phenotypes.

How can researchers apply principles from antibody epitope mapping to advance understanding of YGR168C/PEX35 functional domains?

Techniques developed for epitope mapping of antibodies can be powerfully applied to understand YGR168C/PEX35 functional domains. Drawing from methodologies used in SARS-CoV-2 antibody research , researchers can:

• Generate domain-specific antibodies:

  • Develop antibodies targeting different regions of YGR168C/PEX35

  • Use these antibodies as probes for domain accessibility and function

  • Map binding sites precisely through structural biology approaches

• Apply competitive binding analysis:

  • Assess whether different antibodies compete for binding to YGR168C/PEX35

  • Non-competing antibodies likely target distinct functional domains

  • This approach can reveal domain organization without requiring crystal structures

• Utilize tripartite complex formation:

  • Similar to the BD-236/RBD/BD-368-2 approach used in SARS-CoV-2 research

  • Determine whether multiple antibodies can simultaneously bind YGR168C/PEX35

  • This information helps map distinct functional surfaces on the protein

• Correlate with functional assays:

  • Test how antibody binding to specific domains affects protein function

  • Use domain-specific antibodies to block protein-protein interactions

  • Identify critical functional regions through antibody-mediated inhibition

These approaches leverage antibodies not just as detection tools but as probes for understanding protein structure-function relationships.